Tectonic Therapeutic | AVRO - مصاريف البيع والإدارة

سعر السهم
28.54
التغيير اليومي
0.10 0.35%
شهريا
-8.11%
سنويا
35.32%
Q2 التوقعات
27.93




مصاريف البيع والإدارة تغيير تاريخ
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Celltrion KRW 249.98B 16.36B 2025-09
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Gilead Sciences USD 1.78B 425M 2025-12
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
MacroGenics USD 7.94M 1.96M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Ovoca Bio EUR 632K 2.33M 2025-06
Pfizer USD 4.08B 894M 2025-12
Pharma Mar EUR 17.31M 3.6M 2025-12
Qiagen NV USD 153.88M 10.77M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.33B 419M 2026-03
Sarepta Therapeutics USD 105.38M 28.27M 2025-12
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Takeda JPY 282.78B 29.23B 2025-12
Tilray USD 24.85M 1.7M 2025-09
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 171.91M 343.2M 2025-09